

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.59805246 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.59805246 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.59805246 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.59805246 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.59805246 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.59805246 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.81406954 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 5.68844680 |
| 9 | mannose metabolic process (GO:0006013) | 4.86791890 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.81578765 |
| 11 | detection of molecule of bacterial origin (GO:0032490) | 4.55012868 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 4.52679079 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.50316219 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.50316219 |
| 15 | nuclear pore complex assembly (GO:0051292) | 4.48153926 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 4.41579971 |
| 17 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.38993665 |
| 18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.30245419 |
| 19 | response to host immune response (GO:0052572) | 4.30245419 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.28911314 |
| 21 | negative regulation of cell killing (GO:0031342) | 4.28911314 |
| 22 | microglial cell activation (GO:0001774) | 4.27754245 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.20960431 |
| 24 | positive regulation of interferon-beta production (GO:0032728) | 4.14259375 |
| 25 | peptidyl-lysine dimethylation (GO:0018027) | 4.06753805 |
| 26 | DNA unwinding involved in DNA replication (GO:0006268) | 4.05996217 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04387961 |
| 28 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.02946781 |
| 29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.93023526 |
| 30 | response to host (GO:0075136) | 3.93023526 |
| 31 | response to host defenses (GO:0052200) | 3.93023526 |
| 32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.89299769 |
| 33 | nuclear pore organization (GO:0006999) | 3.84835024 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 3.80969048 |
| 35 | glucose 6-phosphate metabolic process (GO:0051156) | 3.80546478 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.80403372 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.78601521 |
| 38 | meiotic chromosome segregation (GO:0045132) | 3.76623539 |
| 39 | detection of other organism (GO:0098543) | 3.76476608 |
| 40 | response to peptidoglycan (GO:0032494) | 3.76197727 |
| 41 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.76066177 |
| 42 | regulation of interferon-beta production (GO:0032648) | 3.72796514 |
| 43 | positive regulation of histone deacetylation (GO:0031065) | 3.71113600 |
| 44 | natural killer cell differentiation (GO:0001779) | 3.69921379 |
| 45 | GDP-mannose metabolic process (GO:0019673) | 3.68068948 |
| 46 | macrophage activation (GO:0042116) | 3.66091681 |
| 47 | regulation of gamma-delta T cell activation (GO:0046643) | 3.56206296 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.44957327 |
| 49 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.44864864 |
| 50 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.43542295 |
| 51 | cellular response to virus (GO:0098586) | 3.43487278 |
| 52 | Peyers patch development (GO:0048541) | 3.42720593 |
| 53 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.42720593 |
| 54 | neutrophil activation involved in immune response (GO:0002283) | 3.42546117 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.42248993 |
| 56 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 3.40357301 |
| 57 | detection of bacterium (GO:0016045) | 3.40048857 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 3.38095174 |
| 59 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.36853088 |
| 60 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.36853088 |
| 61 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.36853088 |
| 62 | cellular extravasation (GO:0045123) | 3.36307617 |
| 63 | histone H3-K36 demethylation (GO:0070544) | 3.34386952 |
| 64 | regulation of histone H3-K9 methylation (GO:0051570) | 3.33382626 |
| 65 | mitotic chromosome condensation (GO:0007076) | 3.31777110 |
| 66 | mitotic sister chromatid cohesion (GO:0007064) | 3.31705816 |
| 67 | mRNA stabilization (GO:0048255) | 3.29109008 |
| 68 | RNA stabilization (GO:0043489) | 3.29109008 |
| 69 | dosage compensation (GO:0007549) | 3.26105955 |
| 70 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.25571120 |
| 71 | I-kappaB phosphorylation (GO:0007252) | 3.24071112 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 3.23908182 |
| 73 | detection of biotic stimulus (GO:0009595) | 3.23089619 |
| 74 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.19146490 |
| 75 | regulation of RNA export from nucleus (GO:0046831) | 3.18843874 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 3.17201664 |
| 77 | leukocyte aggregation (GO:0070486) | 3.14535272 |
| 78 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.10558753 |
| 79 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.09682001 |
| 80 | interferon-gamma production (GO:0032609) | 3.07071498 |
| 81 | response to type I interferon (GO:0034340) | 3.06172558 |
| 82 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05368400 |
| 83 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.03894829 |
| 84 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.03138378 |
| 85 | neutrophil mediated immunity (GO:0002446) | 3.02250284 |
| 86 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.01033664 |
| 87 | cellular response to type I interferon (GO:0071357) | 3.00710479 |
| 88 | type I interferon signaling pathway (GO:0060337) | 3.00710479 |
| 89 | positive regulation of protein deacetylation (GO:0090312) | 3.00657300 |
| 90 | B cell proliferation (GO:0042100) | 3.00568883 |
| 91 | positive T cell selection (GO:0043368) | 2.96556739 |
| 92 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.95470276 |
| 93 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93865036 |
| 94 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.93523209 |
| 95 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.90215456 |
| 96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.89280731 |
| 97 | negative regulation of histone methylation (GO:0031061) | 2.88774139 |
| 98 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.88158864 |
| 99 | germinal center formation (GO:0002467) | 2.87022327 |
| 100 | corticosteroid receptor signaling pathway (GO:0031958) | 2.84863310 |
| 101 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.83713020 |
| 102 | respiratory burst (GO:0045730) | 2.83468077 |
| 103 | pore complex assembly (GO:0046931) | 2.83407454 |
| 104 | maternal placenta development (GO:0001893) | 2.81661094 |
| 105 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.80280900 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.78298341 |
| 107 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.77402063 |
| 108 | immunoglobulin mediated immune response (GO:0016064) | 2.76106963 |
| 109 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.74361484 |
| 110 | chromatin assembly (GO:0031497) | 2.71658476 |
| 111 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.70032171 |
| 112 | granulocyte differentiation (GO:0030851) | 2.68596538 |
| 113 | positive regulation of lamellipodium assembly (GO:0010592) | 2.66549901 |
| 114 | DNA duplex unwinding (GO:0032508) | 2.66445162 |
| 115 | DNA geometric change (GO:0032392) | 2.66387379 |
| 116 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.66292245 |
| 117 | megakaryocyte development (GO:0035855) | 2.65862863 |
| 118 | negative T cell selection (GO:0043383) | 2.65749313 |
| 119 | T cell homeostasis (GO:0043029) | 2.65555908 |
| 120 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.65510018 |
| 121 | defense response to protozoan (GO:0042832) | 2.64500123 |
| 122 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.63583661 |
| 123 | myeloid leukocyte mediated immunity (GO:0002444) | 2.62751444 |
| 124 | cellular response to ethanol (GO:0071361) | 2.62026031 |
| 125 | regulation of B cell differentiation (GO:0045577) | 2.61814410 |
| 126 | heterochromatin organization (GO:0070828) | 2.61085552 |
| 127 | negative thymic T cell selection (GO:0045060) | 2.60539540 |
| 128 | pre-miRNA processing (GO:0031054) | 2.60511409 |
| 129 | negative regulation of RNA splicing (GO:0033119) | 2.60302061 |
| 130 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60104250 |
| 131 | negative regulation of phagocytosis (GO:0050765) | 2.59642909 |
| 132 | response to epidermal growth factor (GO:0070849) | 2.58964598 |
| 133 | negative regulation of B cell proliferation (GO:0030889) | 2.58614835 |
| 134 | histone phosphorylation (GO:0016572) | 2.58448372 |
| 135 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57558037 |
| 136 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.57338052 |
| 137 | T cell migration (GO:0072678) | 2.55550835 |
| 138 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.55297918 |
| 139 | regulation of erythrocyte differentiation (GO:0045646) | 2.54739266 |
| 140 | regulation of protein polyubiquitination (GO:1902914) | 2.53673115 |
| 141 | purinergic receptor signaling pathway (GO:0035587) | 2.52626932 |
| 142 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.52320001 |
| 143 | tolerance induction (GO:0002507) | 2.50036440 |
| 144 | response to protozoan (GO:0001562) | 2.50031606 |
| 145 | regulation of sister chromatid cohesion (GO:0007063) | 2.49444163 |
| 146 | regulation of mast cell degranulation (GO:0043304) | 2.48669663 |
| 147 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.47651295 |
| 148 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.46860150 |
| 149 | T cell selection (GO:0045058) | 2.46344632 |
| 150 | regulation of antigen processing and presentation (GO:0002577) | 2.46233757 |
| 151 | necroptotic process (GO:0070266) | 2.46055685 |
| 152 | histone mRNA catabolic process (GO:0071044) | 2.45771273 |
| 153 | response to muramyl dipeptide (GO:0032495) | 2.45630890 |
| 154 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.45460111 |
| 155 | B cell mediated immunity (GO:0019724) | 2.44188525 |
| 156 | necrotic cell death (GO:0070265) | 2.43876147 |
| 157 | adenosine receptor signaling pathway (GO:0001973) | 2.43635430 |
| 158 | regulation of mRNA stability (GO:0043488) | 2.43313299 |
| 159 | positive thymic T cell selection (GO:0045059) | 2.43019393 |
| 160 | programmed necrotic cell death (GO:0097300) | 2.42371610 |
| 161 | negative regulation of type I interferon production (GO:0032480) | 2.41023327 |
| 162 | positive regulation of chromosome segregation (GO:0051984) | 2.40937168 |
| 163 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.40439019 |
| 164 | regulation of necroptotic process (GO:0060544) | 2.37570691 |
| 165 | negative regulation of T cell mediated immunity (GO:0002710) | 2.37491167 |
| 166 | histone H3-K9 modification (GO:0061647) | 2.37212521 |
| 167 | negative regulation of granulocyte differentiation (GO:0030853) | 2.37048290 |
| 168 | gene silencing by RNA (GO:0031047) | 2.36602266 |
| 169 | positive regulation of lamellipodium organization (GO:1902745) | 2.36434644 |
| 170 | definitive hemopoiesis (GO:0060216) | 2.36429031 |
| 171 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.35268034 |
| 172 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.35268034 |
| 173 | mature B cell differentiation (GO:0002335) | 2.35163603 |
| 174 | ncRNA 3-end processing (GO:0043628) | 2.33586122 |
| 175 | histone H3-K9 methylation (GO:0051567) | 2.32351001 |
| 176 | histone H3-K4 trimethylation (GO:0080182) | 2.31905251 |
| 177 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.31267225 |
| 178 | regulation of RNA stability (GO:0043487) | 2.30862305 |
| 179 | cellular hyperosmotic response (GO:0071474) | 2.30351909 |
| 180 | chromosome condensation (GO:0030261) | 2.29807809 |
| 181 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.28553697 |
| 182 | response to interleukin-15 (GO:0070672) | 2.27981135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.90210392 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.86688147 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.88246053 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.75849081 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.56221007 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.45729020 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.29320999 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.79521855 |
| 9 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.77813886 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.69204451 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60577573 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51260526 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.49000182 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47641942 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.26808629 |
| 16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.25020417 |
| 17 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.22967499 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.09099420 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07774776 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.04321487 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.01920352 |
| 22 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.00625796 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98790420 |
| 24 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97644005 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.95873599 |
| 26 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.95355455 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93039578 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.92283754 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.91544767 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.91446140 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90330356 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90182926 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.89619571 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87605213 |
| 35 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.80583905 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78458049 |
| 37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.76860583 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75941681 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.74116663 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71781373 |
| 41 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.70564573 |
| 42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70548555 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.69643713 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.66106022 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.65976725 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65898546 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65835691 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65685097 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65103655 |
| 50 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.58213976 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52630550 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52044889 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50795739 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.45644539 |
| 55 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44212163 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42443342 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40951813 |
| 58 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40031022 |
| 59 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39510395 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39357717 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.38671888 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35200460 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34055741 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32436142 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.30204356 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29936528 |
| 67 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28544032 |
| 68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28443896 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.25316567 |
| 70 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24608626 |
| 71 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.23258222 |
| 72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.23083885 |
| 73 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20942860 |
| 74 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20214511 |
| 75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19791517 |
| 76 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.19068459 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18931230 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18474048 |
| 79 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.18130932 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17686483 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16666213 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16042489 |
| 83 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.13966083 |
| 84 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13703549 |
| 85 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.13347595 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11825934 |
| 87 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.11510556 |
| 88 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11059366 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09543066 |
| 90 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.09422789 |
| 91 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07919639 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.07794982 |
| 93 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.07537516 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07496799 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05722479 |
| 96 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05380789 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05052261 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04568867 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04384935 |
| 100 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03423351 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01576679 |
| 102 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01405557 |
| 103 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.01197585 |
| 104 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00489527 |
| 105 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00383704 |
| 106 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.00289648 |
| 107 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99468433 |
| 108 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99152437 |
| 109 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.98157892 |
| 110 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98066347 |
| 111 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97812165 |
| 112 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97204587 |
| 113 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96699045 |
| 114 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.96434350 |
| 115 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 0.96235906 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95533135 |
| 117 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94686144 |
| 118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94627995 |
| 119 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.93529419 |
| 120 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91784368 |
| 121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90737300 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90462760 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89311920 |
| 124 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88622657 |
| 125 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88341540 |
| 126 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87469645 |
| 127 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86120206 |
| 128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84713655 |
| 129 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.83532256 |
| 130 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83513053 |
| 131 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.82694670 |
| 132 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81455380 |
| 133 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80944927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 3.41834481 |
| 2 | MP0010352_gastrointestinal_tract_polyps | 3.18656937 |
| 3 | MP0002396_abnormal_hematopoietic_system | 2.93803454 |
| 4 | MP0003303_peritoneal_inflammation | 2.90029587 |
| 5 | MP0008260_abnormal_autophagy | 2.89961820 |
| 6 | MP0000685_abnormal_immune_system | 2.53050433 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.51560989 |
| 8 | MP0001545_abnormal_hematopoietic_system | 2.26881790 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.26881790 |
| 10 | MP0004808_abnormal_hematopoietic_stem | 2.25259086 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.23819381 |
| 12 | MP0005076_abnormal_cell_differentiation | 2.18419356 |
| 13 | MP0005671_abnormal_response_to | 2.17207996 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.10023862 |
| 15 | MP0002398_abnormal_bone_marrow | 2.02563243 |
| 16 | MP0000015_abnormal_ear_pigmentation | 2.00490246 |
| 17 | MP0001800_abnormal_humoral_immune | 1.92067412 |
| 18 | MP0004510_myositis | 1.83525217 |
| 19 | MP0005360_urolithiasis | 1.79549968 |
| 20 | MP0001915_intracranial_hemorrhage | 1.79475200 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.79198336 |
| 22 | MP0005451_abnormal_body_composition | 1.78953508 |
| 23 | MP0010155_abnormal_intestine_physiology | 1.73375889 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.72653097 |
| 25 | MP0003436_decreased_susceptibility_to | 1.68667033 |
| 26 | MP0009278_abnormal_bone_marrow | 1.68152467 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.67468157 |
| 28 | MP0004185_abnormal_adipocyte_glucose | 1.66138471 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.65929351 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.65329425 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.65149198 |
| 32 | MP0010094_abnormal_chromosome_stability | 1.65132411 |
| 33 | MP0004957_abnormal_blastocyst_morpholog | 1.64859364 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.64278042 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.61644080 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.60180404 |
| 37 | MP0003693_abnormal_embryo_hatching | 1.59644156 |
| 38 | MP0000490_abnormal_crypts_of | 1.59423163 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.57731327 |
| 40 | MP0003111_abnormal_nucleus_morphology | 1.56927660 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.55635187 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.55594659 |
| 43 | MP0001293_anophthalmia | 1.55577150 |
| 44 | MP0010307_abnormal_tumor_latency | 1.55398128 |
| 45 | MP0001819_abnormal_immune_cell | 1.54887984 |
| 46 | MP0004264_abnormal_extraembryonic_tissu | 1.52094232 |
| 47 | MP0003252_abnormal_bile_duct | 1.51425404 |
| 48 | MP0002722_abnormal_immune_system | 1.50077837 |
| 49 | MP0009764_decreased_sensitivity_to | 1.49558406 |
| 50 | MP0000716_abnormal_immune_system | 1.46960258 |
| 51 | MP0005083_abnormal_biliary_tract | 1.46537120 |
| 52 | MP0002723_abnormal_immune_serum | 1.46241577 |
| 53 | MP0004130_abnormal_muscle_cell | 1.46234003 |
| 54 | MP0005310_abnormal_salivary_gland | 1.46047334 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.42877553 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.42574322 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.40728831 |
| 58 | MP0005000_abnormal_immune_tolerance | 1.39184460 |
| 59 | MP0001790_abnormal_immune_system | 1.38832099 |
| 60 | MP0005387_immune_system_phenotype | 1.38832099 |
| 61 | MP0003077_abnormal_cell_cycle | 1.37960662 |
| 62 | MP0005025_abnormal_response_to | 1.37380304 |
| 63 | MP0002429_abnormal_blood_cell | 1.34905322 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.31493351 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.28655990 |
| 66 | MP0000350_abnormal_cell_proliferation | 1.27664628 |
| 67 | MP0000858_altered_metastatic_potential | 1.26820206 |
| 68 | MP0002019_abnormal_tumor_incidence | 1.24342074 |
| 69 | MP0000609_abnormal_liver_physiology | 1.23372926 |
| 70 | MP0002419_abnormal_innate_immunity | 1.21180810 |
| 71 | MP0002086_abnormal_extraembryonic_tissu | 1.20615073 |
| 72 | MP0010329_abnormal_lipoprotein_level | 1.19064215 |
| 73 | MP0002132_abnormal_respiratory_system | 1.18148405 |
| 74 | MP0003828_pulmonary_edema | 1.18059546 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 1.17226697 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.16519004 |
| 77 | MP0002139_abnormal_hepatobiliary_system | 1.16469116 |
| 78 | MP0002006_tumorigenesis | 1.16273500 |
| 79 | MP0001348_abnormal_lacrimal_gland | 1.15834586 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 1.15303620 |
| 81 | MP0003221_abnormal_cardiomyocyte_apopto | 1.13300779 |
| 82 | MP0002405_respiratory_system_inflammati | 1.13205784 |
| 83 | MP0002254_reproductive_system_inflammat | 1.13126373 |
| 84 | MP0005365_abnormal_bile_salt | 1.10477580 |
| 85 | MP0008469_abnormal_protein_level | 1.10235520 |
| 86 | MP0009785_altered_susceptibility_to | 1.06597666 |
| 87 | MP0008877_abnormal_DNA_methylation | 1.05397877 |
| 88 | MP0004947_skin_inflammation | 1.05366636 |
| 89 | MP0001845_abnormal_inflammatory_respons | 1.05113318 |
| 90 | MP0005666_abnormal_adipose_tissue | 1.03979836 |
| 91 | MP0001873_stomach_inflammation | 1.03891495 |
| 92 | MP0009840_abnormal_foam_cell | 1.02650724 |
| 93 | MP0005174_abnormal_tail_pigmentation | 0.97294361 |
| 94 | MP0003091_abnormal_cell_migration | 0.96788189 |
| 95 | MP0005621_abnormal_cell_physiology | 0.96518036 |
| 96 | MP0008057_abnormal_DNA_replication | 0.96471795 |
| 97 | MP0005023_abnormal_wound_healing | 0.96049366 |
| 98 | MP0001730_embryonic_growth_arrest | 0.94851001 |
| 99 | MP0001697_abnormal_embryo_size | 0.93936708 |
| 100 | MP0000477_abnormal_intestine_morphology | 0.93450588 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.93023328 |
| 102 | MP0005085_abnormal_gallbladder_physiolo | 0.92860130 |
| 103 | MP0006054_spinal_hemorrhage | 0.92675346 |
| 104 | MP0002089_abnormal_postnatal_growth/wei | 0.92119892 |
| 105 | MP0001663_abnormal_digestive_system | 0.91432928 |
| 106 | MP0008007_abnormal_cellular_replicative | 0.91139569 |
| 107 | MP0000313_abnormal_cell_death | 0.90860110 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.90592579 |
| 109 | MP0003448_altered_tumor_morphology | 0.90042531 |
| 110 | MP0004883_abnormal_blood_vessel | 0.89519564 |
| 111 | MP0000598_abnormal_liver_morphology | 0.89155643 |
| 112 | MP0006082_CNS_inflammation | 0.88913067 |
| 113 | MP0003890_abnormal_embryonic-extraembry | 0.88730306 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.88728111 |
| 115 | MP0003984_embryonic_growth_retardation | 0.88617340 |
| 116 | MP0000733_abnormal_muscle_development | 0.88574022 |
| 117 | MP0002088_abnormal_embryonic_growth/wei | 0.88391449 |
| 118 | MP0004197_abnormal_fetal_growth/weight/ | 0.87988899 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.86524645 |
| 120 | MP0003724_increased_susceptibility_to | 0.85496795 |
| 121 | MP0002092_abnormal_eye_morphology | 0.83741157 |
| 122 | MP0002080_prenatal_lethality | 0.83578569 |
| 123 | MP0001672_abnormal_embryogenesis/_devel | 0.83454532 |
| 124 | MP0005380_embryogenesis_phenotype | 0.83454532 |
| 125 | MP0001853_heart_inflammation | 0.83161883 |
| 126 | MP0003123_paternal_imprinting | 0.82924156 |
| 127 | MP0005058_abnormal_lysosome_morphology | 0.81808836 |
| 128 | MP0004381_abnormal_hair_follicle | 0.80477286 |
| 129 | MP0003806_abnormal_nucleotide_metabolis | 0.79007805 |
| 130 | MP0005164_abnormal_response_to | 0.78793095 |
| 131 | MP0004043_abnormal_pH_regulation | 0.77411589 |
| 132 | MP0005384_cellular_phenotype | 0.75884827 |
| 133 | MP0009765_abnormal_xenobiotic_induced | 0.74582203 |
| 134 | MP0009763_increased_sensitivity_to | 0.74374886 |
| 135 | MP0008058_abnormal_DNA_repair | 0.72401379 |
| 136 | MP0000371_diluted_coat_color | 0.70488667 |
| 137 | MP0005171_absent_coat_pigmentation | 0.66266649 |
| 138 | MP0000358_abnormal_cell_content/ | 0.65306226 |
| 139 | MP0003646_muscle_fatigue | 0.64796671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.72858848 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.26352885 |
| 3 | Abnormality of macrophages (HP:0004311) | 3.86690841 |
| 4 | Orchitis (HP:0100796) | 3.85814333 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.59590224 |
| 6 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.57174326 |
| 7 | Recurrent cutaneous fungal infections (HP:0011370) | 3.57174326 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.56234153 |
| 9 | Optic neuritis (HP:0100653) | 3.56234153 |
| 10 | Abnormal gallbladder physiology (HP:0012438) | 3.55647873 |
| 11 | Cholecystitis (HP:0001082) | 3.55647873 |
| 12 | Birth length less than 3rd percentile (HP:0003561) | 3.45891124 |
| 13 | Absent eyelashes (HP:0000561) | 3.44537926 |
| 14 | Recurrent skin infections (HP:0001581) | 3.38506184 |
| 15 | Absent eyebrow (HP:0002223) | 3.36892475 |
| 16 | Dyschromatopsia (HP:0007641) | 3.14561946 |
| 17 | Abnormality of the fingertips (HP:0001211) | 3.08701627 |
| 18 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.01415039 |
| 19 | Deep palmar crease (HP:0006191) | 2.92243263 |
| 20 | Meningitis (HP:0001287) | 2.85266346 |
| 21 | Hypoplasia of the pons (HP:0012110) | 2.78228953 |
| 22 | Thrombocytosis (HP:0001894) | 2.77535731 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 2.77527429 |
| 24 | Breast hypoplasia (HP:0003187) | 2.76134616 |
| 25 | Agammaglobulinemia (HP:0004432) | 2.74478061 |
| 26 | Abnormality of the pons (HP:0007361) | 2.73207918 |
| 27 | Obstructive lung disease (HP:0006536) | 2.60776878 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60776878 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 2.60076581 |
| 30 | Encephalitis (HP:0002383) | 2.58770098 |
| 31 | Midline defect of the nose (HP:0004122) | 2.57909990 |
| 32 | Nasal polyposis (HP:0100582) | 2.56557083 |
| 33 | Recurrent viral infections (HP:0004429) | 2.53523252 |
| 34 | Intestinal fistula (HP:0100819) | 2.52430712 |
| 35 | Skull defect (HP:0001362) | 2.49990533 |
| 36 | Stomatitis (HP:0010280) | 2.48885325 |
| 37 | Persistence of primary teeth (HP:0006335) | 2.47003146 |
| 38 | Recurrent bronchitis (HP:0002837) | 2.45598148 |
| 39 | Squamous cell carcinoma (HP:0002860) | 2.45014252 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 2.44489600 |
| 41 | Gingivitis (HP:0000230) | 2.44161304 |
| 42 | Progressive external ophthalmoplegia (HP:0000590) | 2.41115326 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 2.40937955 |
| 44 | Reticulocytosis (HP:0001923) | 2.39566094 |
| 45 | IgM deficiency (HP:0002850) | 2.38857008 |
| 46 | Rectal fistula (HP:0100590) | 2.38251483 |
| 47 | Rectovaginal fistula (HP:0000143) | 2.38251483 |
| 48 | Anorexia (HP:0002039) | 2.38110209 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.36912450 |
| 50 | Recurrent pneumonia (HP:0006532) | 2.35145305 |
| 51 | Abnormal platelet volume (HP:0011876) | 2.34878734 |
| 52 | Hypochromic anemia (HP:0001931) | 2.34839952 |
| 53 | Vasculitis (HP:0002633) | 2.30579654 |
| 54 | Hematochezia (HP:0002573) | 2.29725172 |
| 55 | Hyperacusis (HP:0010780) | 2.28182794 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.23393473 |
| 57 | Osteomyelitis (HP:0002754) | 2.21705064 |
| 58 | Petechiae (HP:0000967) | 2.21658097 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.21464785 |
| 60 | Abnormality of the common coagulation pathway (HP:0010990) | 2.20053802 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.19680914 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.19440241 |
| 63 | Abnormality of reticulocytes (HP:0004312) | 2.18954516 |
| 64 | Hemorrhage of the eye (HP:0011885) | 2.17946833 |
| 65 | Leukocytosis (HP:0001974) | 2.12701578 |
| 66 | Increased mean platelet volume (HP:0011877) | 2.12677600 |
| 67 | Rib fusion (HP:0000902) | 2.12665865 |
| 68 | Basal cell carcinoma (HP:0002671) | 2.12361460 |
| 69 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.12130296 |
| 70 | Short 4th metacarpal (HP:0010044) | 2.12130296 |
| 71 | Acute myeloid leukemia (HP:0004808) | 2.09935921 |
| 72 | Cellulitis (HP:0100658) | 2.09608408 |
| 73 | IgA deficiency (HP:0002720) | 2.09054557 |
| 74 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.08536361 |
| 75 | Vaginal fistula (HP:0004320) | 2.08455335 |
| 76 | Chronic otitis media (HP:0000389) | 2.07640374 |
| 77 | Poikiloderma (HP:0001029) | 2.06294757 |
| 78 | Cutis marmorata (HP:0000965) | 2.06150181 |
| 79 | T lymphocytopenia (HP:0005403) | 2.05852624 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.05055319 |
| 81 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.04512422 |
| 82 | Chromsome breakage (HP:0040012) | 2.04123109 |
| 83 | Myelodysplasia (HP:0002863) | 2.04013435 |
| 84 | Truncal obesity (HP:0001956) | 2.03903067 |
| 85 | Joint hemorrhage (HP:0005261) | 2.03658073 |
| 86 | Increased density of long bones (HP:0006392) | 2.02928232 |
| 87 | Morphological abnormality of the middle ear (HP:0008609) | 2.02539053 |
| 88 | Lymphopenia (HP:0001888) | 2.01173276 |
| 89 | Wide nose (HP:0000445) | 2.00502309 |
| 90 | Gingival bleeding (HP:0000225) | 1.99889812 |
| 91 | Recurrent fungal infections (HP:0002841) | 1.99535176 |
| 92 | Spastic diplegia (HP:0001264) | 1.99053649 |
| 93 | Abnormality of chromosome stability (HP:0003220) | 1.98325053 |
| 94 | Prolonged partial thromboplastin time (HP:0003645) | 1.98066500 |
| 95 | Thyroiditis (HP:0100646) | 1.98065685 |
| 96 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97286351 |
| 97 | Bilateral microphthalmos (HP:0007633) | 1.96203868 |
| 98 | Visual hallucinations (HP:0002367) | 1.95163869 |
| 99 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94982292 |
| 100 | Increased serum ferritin (HP:0003281) | 1.93825557 |
| 101 | Hypochromic microcytic anemia (HP:0004840) | 1.92706724 |
| 102 | Viral hepatitis (HP:0006562) | 1.92390014 |
| 103 | Hypoplasia of the thymus (HP:0000778) | 1.92081092 |
| 104 | Dysmetric saccades (HP:0000641) | 1.91645766 |
| 105 | Abnormality of T cell number (HP:0011839) | 1.91319676 |
| 106 | Purpura (HP:0000979) | 1.91282742 |
| 107 | Pustule (HP:0200039) | 1.91114235 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 1.90804609 |
| 109 | Heterotopia (HP:0002282) | 1.89700642 |
| 110 | Gastrointestinal stroma tumor (HP:0100723) | 1.89650362 |
| 111 | Subacute progressive viral hepatitis (HP:0006572) | 1.89383316 |
| 112 | Testicular atrophy (HP:0000029) | 1.88575320 |
| 113 | Arterial thrombosis (HP:0004420) | 1.87434356 |
| 114 | Leukopenia (HP:0001882) | 1.86656046 |
| 115 | Gastrointestinal inflammation (HP:0004386) | 1.86379416 |
| 116 | Achilles tendon contracture (HP:0001771) | 1.86154539 |
| 117 | Abnormality of the Achilles tendon (HP:0005109) | 1.86103060 |
| 118 | Myositis (HP:0100614) | 1.85828067 |
| 119 | Submucous cleft hard palate (HP:0000176) | 1.85622082 |
| 120 | Periodontitis (HP:0000704) | 1.85433902 |
| 121 | Urticaria (HP:0001025) | 1.85296432 |
| 122 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.84450165 |
| 123 | Abnormality of the thymus (HP:0000777) | 1.83791385 |
| 124 | B lymphocytopenia (HP:0010976) | 1.83702297 |
| 125 | Abnormality of B cell number (HP:0010975) | 1.83702297 |
| 126 | Hypoalbuminemia (HP:0003073) | 1.83598157 |
| 127 | Abnormal albumin level (HP:0012116) | 1.83598157 |
| 128 | Broad palm (HP:0001169) | 1.82615722 |
| 129 | Reticulocytopenia (HP:0001896) | 1.82311713 |
| 130 | Entropion (HP:0000621) | 1.82166006 |
| 131 | Biliary tract neoplasm (HP:0100574) | 1.82083525 |
| 132 | Papilloma (HP:0012740) | 1.81822175 |
| 133 | Verrucae (HP:0200043) | 1.81822175 |
| 134 | Peritonitis (HP:0002586) | 1.80766155 |
| 135 | Volvulus (HP:0002580) | 1.80556960 |
| 136 | Lymphoma (HP:0002665) | 1.80307809 |
| 137 | Colitis (HP:0002583) | 1.80234054 |
| 138 | Facial diplegia (HP:0001349) | 1.80224485 |
| 139 | Facial hemangioma (HP:0000329) | 1.80010139 |
| 140 | Choroideremia (HP:0001139) | 1.79515986 |
| 141 | Tracheal stenosis (HP:0002777) | 1.79515219 |
| 142 | Acute lymphatic leukemia (HP:0006721) | 1.79463598 |
| 143 | Eczematoid dermatitis (HP:0000976) | 1.78334721 |
| 144 | Aneurysm (HP:0002617) | 1.78314417 |
| 145 | Pelvic girdle muscle weakness (HP:0003749) | 1.78110520 |
| 146 | Autoimmune thrombocytopenia (HP:0001973) | 1.77380124 |
| 147 | Cholelithiasis (HP:0001081) | 1.77220414 |
| 148 | Hyperbilirubinemia (HP:0002904) | 1.76727961 |
| 149 | Sandal gap (HP:0001852) | 1.76602651 |
| 150 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.76464903 |
| 151 | Short 1st metacarpal (HP:0010034) | 1.76464903 |
| 152 | Macroorchidism (HP:0000053) | 1.76146269 |
| 153 | Epistaxis (HP:0000421) | 1.75998699 |
| 154 | Mitral valve prolapse (HP:0001634) | 1.75307229 |
| 155 | Abnormality of DNA repair (HP:0003254) | 1.75070745 |
| 156 | Genu recurvatum (HP:0002816) | 1.74941372 |
| 157 | Abnormality of the pubic bones (HP:0003172) | 1.74915314 |
| 158 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.74565020 |
| 159 | Abnormality of T cells (HP:0002843) | 1.73436607 |
| 160 | Annular pancreas (HP:0001734) | 1.72865866 |
| 161 | Pointed chin (HP:0000307) | 1.72684248 |
| 162 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.72479430 |
| 163 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.70686262 |
| 164 | Apathy (HP:0000741) | 1.70643543 |
| 165 | Diminished motivation (HP:0000745) | 1.70494389 |
| 166 | Prominent nose (HP:0000448) | 1.70168464 |
| 167 | Inflammation of the large intestine (HP:0002037) | 1.69945413 |
| 168 | Myocardial infarction (HP:0001658) | 1.69055784 |
| 169 | Ependymoma (HP:0002888) | 1.67868436 |
| 170 | Thin bony cortex (HP:0002753) | 1.67294762 |
| 171 | Recurrent sinusitis (HP:0011108) | 1.65522639 |
| 172 | Polygenic inheritance (HP:0010982) | 1.65097860 |
| 173 | Renovascular hypertension (HP:0100817) | 1.61592753 |
| 174 | Cerebral aneurysm (HP:0004944) | 1.61568044 |
| 175 | Chest pain (HP:0100749) | 1.61528130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.07195621 |
| 2 | TRIB3 | 4.00772429 |
| 3 | PKN2 | 3.25896738 |
| 4 | IRAK4 | 2.89570099 |
| 5 | BLK | 2.82607028 |
| 6 | TLK1 | 2.61680846 |
| 7 | MAP3K10 | 2.49001681 |
| 8 | SIK2 | 2.48764605 |
| 9 | EEF2K | 2.47144255 |
| 10 | CDK12 | 2.15480742 |
| 11 | JAK3 | 2.07805528 |
| 12 | FGR | 1.96428499 |
| 13 | ACVR1B | 1.93595259 |
| 14 | AKT3 | 1.91597050 |
| 15 | MAP4K1 | 1.90446693 |
| 16 | NEK2 | 1.79415530 |
| 17 | STK10 | 1.77510027 |
| 18 | ZAK | 1.68462237 |
| 19 | CDC7 | 1.66626438 |
| 20 | IKBKE | 1.63315693 |
| 21 | CDK6 | 1.62978460 |
| 22 | BRD4 | 1.60263403 |
| 23 | FLT3 | 1.59741266 |
| 24 | TGFBR1 | 1.53928245 |
| 25 | KSR2 | 1.53752106 |
| 26 | SIK1 | 1.53436155 |
| 27 | BRSK2 | 1.48106666 |
| 28 | PRPF4B | 1.47115065 |
| 29 | MAP3K14 | 1.45022413 |
| 30 | PTK6 | 1.44520783 |
| 31 | MAP3K11 | 1.41611072 |
| 32 | MAP3K6 | 1.38993682 |
| 33 | CDK4 | 1.34574231 |
| 34 | BMPR1B | 1.32083783 |
| 35 | TAOK1 | 1.29134267 |
| 36 | LRRK2 | 1.27589543 |
| 37 | FES | 1.24075342 |
| 38 | GRK6 | 1.23753159 |
| 39 | ZAP70 | 1.22426226 |
| 40 | TGFBR2 | 1.21287418 |
| 41 | JAK2 | 1.17216932 |
| 42 | TBK1 | 1.16587173 |
| 43 | BMX | 1.15899322 |
| 44 | KIT | 1.14375232 |
| 45 | RET | 1.12947875 |
| 46 | SIK3 | 1.12880652 |
| 47 | MAP3K5 | 1.12637809 |
| 48 | RIPK1 | 1.12475466 |
| 49 | MELK | 1.11156504 |
| 50 | TYK2 | 1.09714236 |
| 51 | PDGFRA | 1.06898389 |
| 52 | CSF1R | 1.05979390 |
| 53 | ERN1 | 1.05780964 |
| 54 | PTK2B | 1.03559730 |
| 55 | RAF1 | 1.02702464 |
| 56 | BRAF | 1.01048970 |
| 57 | RPS6KA4 | 1.00658798 |
| 58 | TEC | 0.99816544 |
| 59 | MAP2K3 | 0.99669167 |
| 60 | WNK1 | 0.98626985 |
| 61 | PDK1 | 0.97375468 |
| 62 | SGK3 | 0.97344406 |
| 63 | MAP3K3 | 0.97064112 |
| 64 | JAK1 | 0.96567648 |
| 65 | SCYL2 | 0.95378525 |
| 66 | FGFR3 | 0.94660737 |
| 67 | STK11 | 0.88996238 |
| 68 | ALK | 0.88637835 |
| 69 | TTN | 0.85837535 |
| 70 | MAP2K6 | 0.85046874 |
| 71 | YES1 | 0.84928240 |
| 72 | MAP3K8 | 0.84903465 |
| 73 | SRPK1 | 0.83917292 |
| 74 | CAMKK1 | 0.81902009 |
| 75 | PIM2 | 0.80971155 |
| 76 | FRK | 0.80224966 |
| 77 | IKBKB | 0.79144332 |
| 78 | TAOK2 | 0.77986345 |
| 79 | SGK2 | 0.77778260 |
| 80 | SYK | 0.77463890 |
| 81 | PDGFRB | 0.77424976 |
| 82 | BTK | 0.77248868 |
| 83 | PRKD2 | 0.76833221 |
| 84 | MAP3K7 | 0.76631934 |
| 85 | HCK | 0.76212695 |
| 86 | CAMKK2 | 0.76165532 |
| 87 | CAMK1D | 0.76140697 |
| 88 | MATK | 0.75531893 |
| 89 | STK3 | 0.74052369 |
| 90 | CAMK1G | 0.73496909 |
| 91 | MAP3K13 | 0.73333686 |
| 92 | PDPK1 | 0.72693834 |
| 93 | PIM1 | 0.72119892 |
| 94 | MST4 | 0.72027543 |
| 95 | MARK2 | 0.70967503 |
| 96 | IRAK2 | 0.69879288 |
| 97 | RPS6KB2 | 0.69108481 |
| 98 | ADRBK1 | 0.68670318 |
| 99 | DMPK | 0.67841020 |
| 100 | FGFR4 | 0.67790667 |
| 101 | MARK3 | 0.67329836 |
| 102 | IRAK3 | 0.67008338 |
| 103 | MKNK2 | 0.67006028 |
| 104 | AKT2 | 0.66840343 |
| 105 | PRKCH | 0.66427514 |
| 106 | MAPK11 | 0.66257534 |
| 107 | MAP2K4 | 0.64193268 |
| 108 | LCK | 0.63798581 |
| 109 | DYRK3 | 0.63261060 |
| 110 | KSR1 | 0.63228436 |
| 111 | CDK7 | 0.63148652 |
| 112 | MAP3K2 | 0.62504694 |
| 113 | TESK2 | 0.58189236 |
| 114 | EPHA4 | 0.56680512 |
| 115 | CDK9 | 0.56222682 |
| 116 | STK38 | 0.53532991 |
| 117 | DDR2 | 0.53016186 |
| 118 | ATR | 0.51779643 |
| 119 | NLK | 0.50703725 |
| 120 | NME2 | 0.49720427 |
| 121 | STK24 | 0.49358555 |
| 122 | DYRK1B | 0.49021508 |
| 123 | MAP4K2 | 0.47814301 |
| 124 | TESK1 | 0.47039135 |
| 125 | ITK | 0.46199013 |
| 126 | CDK19 | 0.45905397 |
| 127 | TYRO3 | 0.44620451 |
| 128 | TNK2 | 0.44601420 |
| 129 | STK4 | 0.42357365 |
| 130 | CDC42BPA | 0.39916900 |
| 131 | LYN | 0.39910745 |
| 132 | IRAK1 | 0.39635696 |
| 133 | MAP3K1 | 0.39374835 |
| 134 | AURKB | 0.39367216 |
| 135 | CHEK2 | 0.38607862 |
| 136 | NEK9 | 0.38394387 |
| 137 | CSK | 0.38127710 |
| 138 | EGFR | 0.37243636 |
| 139 | WEE1 | 0.35891894 |
| 140 | TTK | 0.35566199 |
| 141 | AKT1 | 0.34471258 |
| 142 | MAP2K1 | 0.34171420 |
| 143 | MTOR | 0.33018379 |
| 144 | CHEK1 | 0.32603310 |
| 145 | EPHA3 | 0.32101342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.57987285 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.68293373 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.59745813 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14056977 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.93068010 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 1.82623352 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81190829 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.76463354 |
| 9 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.71516499 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.64544572 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.61565843 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53031690 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.52428110 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46172797 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46017568 |
| 16 | Glioma_Homo sapiens_hsa05214 | 1.39181052 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.37185815 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37029567 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.36969111 |
| 20 | Thyroid cancer_Homo sapiens_hsa05216 | 1.36872737 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.33702496 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33436422 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.32090319 |
| 24 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.31267647 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30215960 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.29915749 |
| 27 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.28353950 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.27766271 |
| 29 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.26367478 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.25198725 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23824076 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23177941 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 1.20375095 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.19952221 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.19015709 |
| 36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.18514379 |
| 37 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.18353774 |
| 38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.17448057 |
| 39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.16509401 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.16020615 |
| 41 | Colorectal cancer_Homo sapiens_hsa05210 | 1.15852989 |
| 42 | Bladder cancer_Homo sapiens_hsa05219 | 1.15157154 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14288582 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13846568 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.10462236 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.09609135 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 1.04235649 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03521006 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01684285 |
| 50 | Measles_Homo sapiens_hsa05162 | 1.01527093 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.99353389 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.98154489 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97702487 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96242741 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.95984437 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95845414 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95364473 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94718354 |
| 59 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.93416270 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93341334 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92009458 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.91155528 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89670824 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89262074 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87220826 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.87068223 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87044999 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.86824067 |
| 69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.86799713 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86120198 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.85186017 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.83806728 |
| 73 | Cell cycle_Homo sapiens_hsa04110 | 0.83742652 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83543900 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.83473709 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.82400309 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81213270 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80319601 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80100310 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.79356663 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76571924 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75762031 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75671032 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75361256 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75331528 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74413121 |
| 87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73813359 |
| 88 | Base excision repair_Homo sapiens_hsa03410 | 0.72255364 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72113003 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71899887 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71722812 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70679107 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70615017 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70336014 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69926818 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69296899 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69060343 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.68435083 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.68091306 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67751631 |
| 101 | Tuberculosis_Homo sapiens_hsa05152 | 0.66653513 |
| 102 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66378804 |
| 103 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65059265 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63702043 |
| 105 | RNA polymerase_Homo sapiens_hsa03020 | 0.63264445 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63152817 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61821372 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61724083 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60483830 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60449147 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60397627 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59381594 |
| 113 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58876552 |
| 114 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.58590495 |
| 115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57165520 |
| 116 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57149497 |
| 117 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56672091 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55436247 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55348303 |
| 120 | Basal transcription factors_Homo sapiens_hsa03022 | 0.54461615 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54264520 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53540098 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53513561 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53474688 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53362851 |
| 126 | Spliceosome_Homo sapiens_hsa03040 | 0.50515152 |
| 127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50475658 |
| 128 | RNA degradation_Homo sapiens_hsa03018 | 0.50365708 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.48354053 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48216639 |
| 131 | Focal adhesion_Homo sapiens_hsa04510 | 0.47238257 |
| 132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47051591 |
| 133 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47044261 |
| 134 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46935597 |
| 135 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45816507 |
| 136 | Legionellosis_Homo sapiens_hsa05134 | 0.45497578 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45435827 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44905698 |
| 139 | Hepatitis C_Homo sapiens_hsa05160 | 0.44502859 |

